EN PL
CASE REPORT
McCune-Albright syndrome
 
More details
Hide details
 
Online publication date: 2011-06-06
 
 
Reumatologia 2011;49(3):187-197
 
KEYWORDS
ABSTRACT
McCune-Albright syndrome (MAS) is a very rare disease characterized by the triad of bone defects, skin hyperpigmentation, and various types of endocrine and non-endocrine manifestations. It falls into the category of sporadic genetic disorders and its exact incidence is unknown. In its more severe forms, the disease manifests itself already in early childhood and can gradually affect more and more organs throughout life. The extent and degree of involvement of affected tissues are heterogeneous due to the mosaicism of the genetic mutation. The disease is the subject of extensive research and new pathogenetic mechanisms are being elucidated, leading to new diagnostic and therapeutic choices. In addition, the authors present a case report of an adult female patient with McCune-Albright syndrome. The clinical picture is dominated by bone involvement, thyroid hyperfunction and persistent hyperestrogenism. The case report underlines the fact that management of patients with McCune-Albright syndrome continues to be a challenge.
 
REFERENCES (11)
1.
Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminate, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: report of five cases. New Eng J Med 1937; 216: 727-746.  .
 
2.
Chan B, Zacharin M. Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J Clin Endocrinol Metab 2006; 91: 2017-2020.  .
 
3.
Lala R, Matarazzo P, Andreo M, et al. Bisphosphonate treatment of bone fibrous dysplasia in McCune-Albright syndrome. J Pediatr Endocrinol Metab 2006; 19 Suppl 2: 583-593.  .
 
4.
Kollerová J, Košťálová Ľ, Koller T, et al. McCune-Albrightov syndróm – 11-ročné skúsenosti s liečbou bisfosfonátmi [McCune-Albright syndrome – 11-years of experience with bisphosphonate treatment]. Osteologický Bulletin 2008; 13: 130.  .
 
5.
Bonat S, Shenker A, Monroe J. Papillary thyroid carcinoma (PTC) in a child with McCune-Albright syndrome (MAS): More than a random association? Abstract Book. 2000 Proc 82nd Ann Mtg Endo Soc. Toronto Canada 2000-2099.  .
 
6.
Matarazzo P, Lala R, Andreo M, et al. McCune-Albright Syndrome: Persistence of autonomuous ovarian hyperfunction during adolescence and early adult age. J Pediatr Endocrinol Metab 2006; 19: 607-617.  .
 
7.
Houston TL, Simmons RM. Ductal carcinoma in situ in a 27-year- old woman with McCune-Albright syndrome. Breast J 2004; 10: 440-442.  .
 
8.
Lala R, Andreo M, Pucci A, Matarazzo P. Persistent hyperestrogenism after precocious puberty in young females with McCune-Albright syndrome. Pediatr Endocrinol Rev 2007; 4: 423-428.  .
 
9.
Laven JS, Lumbroso S, Sultan C, Fauser BC. Management of infertility in a patient presenting with ovarian dysfunction and McCune-Albright syndrome. J Clin Endocrinol Metab 2004; 89: 1076-1078. .
 
10.
Kaplan FS, Fallon MD, Boden SD, et al. Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). New Eng J Med 1988; 319: 421-425. .
 
11.
Lumbroso S, Paris F, Sultan Ch. Activanting Gs alpha mutations: Analysis of 113 patients with signs of McCune-Albright syndrome – A European collaborative study. J Clin Endocrinol Metab 2004; 89: 2107-2113.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top